HEDISON DR
Ozempic is the name-brand version of weekly injectable semaglutide that is FDA-approved for diabetes treatment, while Wegovy is the same injectable approved for obesity treatment
Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
Water, Centella Asiatica Extract (13.1%), Butylene Glycol, Glycerin, Dipropylene Glycol, Niacinamide (20,000ppm), Hydroxyethyl Urea, Sodium Hyaluronate, Allantoin, Panthenol, Glutathione (1,000ppm), Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Adenosine, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Xanthan Gum, Propanediol, Hydroxyacetophenone, 1,2-Hexanediol, Ethylhexylglycerin, Dipotassium Glycyrrhizate, Styrene/Acrylates Copolymer, Citric Acid, Sodium Citrate
Spirulina doesn't contain significant astaxanthin
The new GLP1 is produced by drug maker Eli Lilly, designed to be taken once a day to treat obesity and adults